SPRINT — Sprint Bioscience AB Share News
0.000.00%
Last trade - 00:00- SEK469.54m
- SEK361.22m
- SEK167.17m
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program
Brief: Sprint Bioscience Operating Loss SEK 8.4 Mln
Brief: Sprint Bioscience Q2 Operating Loss Widens To SEK 6.8 Mln
Brief: Sprint Bioscience To Lay Off About 35% Of Its Workforce
Brief: Sprint Bioscience CFO Niklas Axelsson Leaves
Brief: Sprint Bioscience Resolves On Rights Issue Of Shares Of About SEK 31.7 Mln
Brief: Sprint Bioscience Q4 Operating Loss Narrows To SEK 4.9 Million
Brief: Sprint Bioscience Q3 Operating Result Turns To Loss
Brief: Sprint Bioscience Recruits Niklas Axelsson As New CFO
Brief: Sprint Bioscience CFO Mathias Skalmstad Leaves Company
Brief: Sprint Bioscience Q2 Net Sales Up At SEK 16.7 Mln
Brief: Sprint Bioscience Q1 Operating Loss Narrows To SEK 3.7 Mln
Brief: Sprint Bioscience: Positive Preclinical Result In Oncology Program Targeting TREX1
Brief: Sprint Bioscience Q4 Operating Loss Narrows To SEK 5.1 Mln
Brief: Sprint Bioscience Q3 Oper Result Swings To Profit Of SEK 28.4 Mln
Brief: Sprint Bioscience Appoints Johan Emilsson As New CEO